Table 1 Demographic, clinical, and hematological data of AML patients and control groups
From: HOTAIR expression and prognostic impact in acute myeloid leukemia patients
Parameter | Control group | Patients’ group | |
|---|---|---|---|
n = 30 | n = 35 | ||
Age (years) | Mean ± SD | 52.53 ± 16.29 | 41.77 ± 18.53 |
Range | 16-77 | 14-75 | |
Sex | Female | 24 (80.0%) | 19 (54.3%) |
Male | 6 (20.0%) | 16 (45.7%) | |
HSM | No HSM | 10 (33.3%) | 25 (71.4%) |
HSM | 20 (66.7%) | 10 (28.6%) | |
TLC (×103/uL) | Median (IQR) | 5.2 (3.7-8.86) | 26.4 (1.87-69.4) |
Range | 0.6-15.3 | 0.3-376.9 | |
Hb (g/dL) | Mean ± SD | 8.90 ± 3.14 | 8.15 ± 1.81 |
Range | 2.23-14.4 | 3-14.2 | |
PLT (×103/uL) | Median (IQR) | 39 (13-100) | 26 (13-55) |
Range | 6-750 | 4-234 | |
BM blasts % | Mean ± SD | 1.89 ± 0.89 | 67.74 ± 23.65 |
Range | 1-3 | 21-97 | |